BNP Paribas Asset Management Holding S.A. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,991
+2.4%
2,000,0000.0%0.01%0.0%
Q4 2022$1,944
-99.9%
2,000,0000.0%0.01%
-12.5%
Q3 2022$1,940,000
-0.3%
2,000,0000.0%0.01%
+14.3%
Q2 2022$1,946,000
-0.5%
2,000,0000.0%0.01%0.0%
Q1 2022$1,955,000
-2.5%
2,000,0000.0%0.01%0.0%
Q4 2021$2,006,000
+0.5%
2,000,0000.0%0.01%0.0%
Q3 2021$1,997,000
+1.2%
2,000,0000.0%0.01%0.0%
Q2 2021$1,973,000
-4.1%
2,000,0000.0%0.01%
-12.5%
Q1 2021$2,057,000
+8.7%
2,000,0000.0%0.01%
-11.1%
Q4 2020$1,893,000
+3.8%
2,000,0000.0%0.01%
-10.0%
Q3 2020$1,823,000
+4.5%
2,000,0000.0%0.01%
-16.7%
Q2 2020$1,745,000
+5.1%
2,000,0000.0%0.01%
-14.3%
Q1 2020$1,661,000
-3.7%
2,000,0000.0%0.01%
+16.7%
Q4 2019$1,725,000
+3.9%
2,000,0000.0%0.01%
-7.7%
Q3 2019$1,661,000
-73.5%
2,000,000
-72.7%
0.01%
-74.5%
Q2 2019$6,278,0007,330,0000.05%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders